The Burnham Institute
Records under this name other than patents The Burnham Institute holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,994,979 | Conversion of Apoptotic Proteins Formerly held Term ended Term ended Dec 11, 2023 · High confidence | Term ended | Term ended Dec 11, 2023 | High confidence |
| US 7,888,372 | Compositions and Methods for Modulating Bone Mineral Deposition Formerly held Lapsed on the fee record Ended Feb 15, 2023 · Medium confidence | Lapsed on the fee record | Ended Feb 15, 2023 | Medium confidence |
| US RE42,700 | Induction of Apoptosis in Cancer Cells Formerly held Term ended Term ended Dec 2, 2022 · Low confidence | Term ended | Term ended Dec 2, 2022 | Low confidence |
| US 7,812,058 | Methods and Compounds Useful to Induce Apoptosis in Cancer Cells Formerly held Lapsed on the fee record Ended Oct 12, 2022 · High confidence | Lapsed on the fee record | Ended Oct 12, 2022 | High confidence |
| US 7,790,404 | Excitatory Glycine Receptors and Methods Formerly held Lapsed on the fee record Ended Sep 7, 2022 · High confidence | Lapsed on the fee record | Ended Sep 7, 2022 | High confidence |
| US 7,741,521 | Inhibition of Bid-Induced Cell-Death Using Small Organic Molecules Formerly held Lapsed on the fee record Ended Jun 22, 2022 · Medium confidence | Lapsed on the fee record | Ended Jun 22, 2022 | Medium confidence |
| US 7,718,680 | Inhibition of Lethal Factor Protease Activity from Anthrax Toxin Formerly held Lapsed on the fee record Ended May 18, 2022 · Medium confidence | Lapsed on the fee record | Ended May 18, 2022 | Medium confidence |
| US 7,671,021 | Peptides that home to tumor lymphatic vasculature and methods of using same Formerly held Lapsed on the fee record Ended Mar 2, 2022 · USPTO record | Lapsed on the fee record | Ended Mar 2, 2022 | USPTO record |
| US 7,666,391 | Breast homing peptides and methods of identifying same using aminopeptidase P Formerly held Lapsed on the fee record Ended Feb 23, 2022 · USPTO record | Lapsed on the fee record | Ended Feb 23, 2022 | USPTO record |
| US 8,642,283 | Screening assay for agents that alter target of rapamycin activity Formerly held Lapsed on the fee record Ended Feb 4, 2022 · Medium confidence | Lapsed on the fee record | Ended Feb 4, 2022 | Medium confidence |